1. Home
  2. TG vs ABOS Comparison

TG vs ABOS Comparison

Compare TG & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TG
  • ABOS
  • Stock Information
  • Founded
  • TG 1988
  • ABOS 1996
  • Country
  • TG United States
  • ABOS United States
  • Employees
  • TG N/A
  • ABOS N/A
  • Industry
  • TG Metal Fabrications
  • ABOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TG Industrials
  • ABOS Health Care
  • Exchange
  • TG Nasdaq
  • ABOS Nasdaq
  • Market Cap
  • TG 301.0M
  • ABOS 72.7M
  • IPO Year
  • TG 1989
  • ABOS 2021
  • Fundamental
  • Price
  • TG $8.85
  • ABOS $1.31
  • Analyst Decision
  • TG
  • ABOS Strong Buy
  • Analyst Count
  • TG 0
  • ABOS 4
  • Target Price
  • TG N/A
  • ABOS $6.50
  • AVG Volume (30 Days)
  • TG 79.2K
  • ABOS 797.6K
  • Earning Date
  • TG 08-06-2025
  • ABOS 08-12-2025
  • Dividend Yield
  • TG N/A
  • ABOS N/A
  • EPS Growth
  • TG N/A
  • ABOS N/A
  • EPS
  • TG N/A
  • ABOS N/A
  • Revenue
  • TG $617,839,000.00
  • ABOS N/A
  • Revenue This Year
  • TG N/A
  • ABOS N/A
  • Revenue Next Year
  • TG N/A
  • ABOS N/A
  • P/E Ratio
  • TG N/A
  • ABOS N/A
  • Revenue Growth
  • TG 17.42
  • ABOS N/A
  • 52 Week Low
  • TG $4.87
  • ABOS $0.86
  • 52 Week High
  • TG $9.43
  • ABOS $3.60
  • Technical
  • Relative Strength Index (RSI)
  • TG 50.82
  • ABOS 56.77
  • Support Level
  • TG $8.82
  • ABOS $1.21
  • Resistance Level
  • TG $9.23
  • ABOS $1.50
  • Average True Range (ATR)
  • TG 0.25
  • ABOS 0.08
  • MACD
  • TG -0.03
  • ABOS 0.02
  • Stochastic Oscillator
  • TG 26.58
  • ABOS 52.50

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: